Greenwich Lifesciences Inc (GLSI)

$16.17

-0.45

(-2.71%)

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $15.94
    $16.93
    $16.17
    downward going graph

    1.42%

    Downside

    Day's Volatility :5.82%

    Upside

    4.46%

    downward going graph
  • $7.58
    $21.44
    $16.17
    downward going graph

    53.12%

    Downside

    52 Weeks Volatility :64.65%

    Upside

    24.58%

    downward going graph

Returns

PeriodGreenwich Lifesciences IncSector (Health Care)Index (Russel 2000)
3 Months
26.68%
6.5%
0.0%
6 Months
90.6%
7.1%
0.0%
1 Year
85.28%
9.8%
0.0%
3 Years
-59.47%
14.2%
-20.2%

Highlights

Market Capitalization
200.3M
Book Value
$0.4
Earnings Per Share (EPS)
-0.71
Wall Street Target Price
36.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-69.02%
Return On Equity TTM
-109.97%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-9.6M
Diluted Eps TTM
-0.71
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.75
EPS Estimate Next Year
-0.7
EPS Estimate Current Quarter
-0.2
EPS Estimate Next Quarter
-0.2

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Greenwich Lifesciences Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 122.63%

Current $16.17
Target $36.00

Technicals Summary

Sell

Neutral

Buy

Greenwich Lifesciences Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
-2.81%
90.6%
85.28%
-59.47%
232.4%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
NA
NA
NA
-0.75
-1.1
-0.69
NA
0.4
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Buy
$200.3M
232.4%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Greenwich Lifesciences Inc

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 246.0%

Institutional Holdings

  • Vanguard Group Inc

    1.73%
  • Millennium Management LLC

    0.50%
  • Geode Capital Management, LLC

    0.45%
  • BlackRock Inc

    0.44%
  • Goldman Sachs Group Inc

    0.32%
  • Renaissance Technologies Corp

    0.29%

Company Information

Organization
Greenwich Lifesciences Inc
Employees
3
CEO
Mr. Snehal S. Patel
Industry
Health Technology

FAQs